Keyphrases
Trigeminal Autonomic Cephalalgias
100%
Therapeutic Approaches
100%
Clinical Features
100%
Short-lasting Unilateral Neuralgiform Headache Attacks
100%
Intolerant
50%
Cranial Autonomic Symptoms
50%
Molecular Targets
50%
Lateral Hypothalamus
50%
Subconjunctival Injection
50%
Treatment Standards
50%
Somatostatin
50%
Cluster Headache
50%
Transient Receptor Potential Vanilloid 1 (TRPV1)
50%
Vagus Nerve
50%
Sphenopalatine Ganglion
50%
Cervical Spinal Cord
50%
High Cervical
50%
Non-invasive Neuromodulation
50%
Nitric Oxide
50%
Calcitonin Gene-related Peptide
50%
Work Research
50%
Primary Headache
50%
Orexin
50%
Melatonin
50%
Structured Target
50%
Neuromodulation
50%
Neuroimaging Studies
50%
New Drug Targets
50%
Glutamate
50%
Tears
50%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
50%
Therapeutic Target
50%
Neuropeptides
50%
Unilateral Headache
50%
Medicine and Dentistry
Trigeminal Autonomic Cephalalgia
100%
Neuromodulation
100%
Headache
66%
Vanilloid Receptor 1
66%
Clinical Feature
66%
Melatonin
33%
Glutamic Acid
33%
Somatostatin
33%
Calcitonin Gene Related Peptide
33%
Receptor
33%
Neuropeptide
33%
Primary Headache
33%
Hypophysis Adenylate Cyclase Activating Polypeptide
33%
Ganglion
33%
Cluster Headache
33%
Orexin
33%
Nitric Oxide
33%
Vagus Nerve
33%
Combination Therapy
33%
Hemicrania Continua
33%
Neuroscience
Vanilloid Receptor 1
33%
Cervical Nerves
16%